EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Virus‐like particles as powerful vaccination strategy against human viruses

Ikbel Hadj Hassine, Manel Ben M'hadheb iD, Mohammed A Almalki iD, Jawhar Gharbi iD

Reviews in Medical Virology · 2024-01 · 34 (1)

DOI: 10.1002/rmv.2498 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Reviews in Medical Virology, online erschienen am 20.12.2023. Verfasst von Ikbel Hadj Hassine und 3 weiteren Autor:innen. Beteiligte Einrichtung: Virology and Antiviral Strategies Research Unit UR17ES30, Higher Institute of Biotechnology, University of Monastir, Monastir, Tunisia. Hauptthemen laut MEDLINE: Vaccines, Virus-Like Particle, Viruses, Viral Vaccines, Communicable Diseases. Die Arbeit wurde bisher 44-mal zitiert (Crossref) und nennt 176 Literaturangaben. Gefördert von: Deanship of Scientific Research, King Faisal University, Tunisian National agency of research promotion, Ministry of Higher Education and Scientific Research.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Nowadays, viruses are not only seen as causative agents of viral infectious diseases but also as valuable research materials for various biomedical purposes, including recombinant protein production. When expressed in living or cell‐free expression systems, viral structural proteins self‐assemble into virus‐like particles (VLPs). Mimicking the native form and size of viruses and lacking the genetic material, VLPs are safe and highly immunogenic and thus can be exploited to develop antiviral vaccines. Some vaccines based on VLPs against various infectious pathogens have already been licenced for human use and are available in the commercial market, the latest of which is a VLP‐based vaccine to protect against the novel Coronavirus. Despite the success and popularity of VLP subunit vaccines, many more VLPs are still in different stages of design, production, and approval. There are still many challenges that require to be addressed in the future before this surface display system can be widely used as an effective vaccine strategy in combating infectious diseases. In this review, we highlight the use of structural viral proteins to produce VLPs, emphasising their intrinsic properties, structural classification, and main expression host systems. We also compiled the recent scientific literature about VLP‐based vaccines to underline the recent advances in their application as a vaccine strategy for preventing and fighting virulent human pathogens. Finally, we presented the key challenges and possible solutions for VLP‐based vaccine production.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Vaccines, Virus-Like ParticleVirusesViral VaccinesCommunicable DiseasesHumansVaccination

Stichwörter der Autor:innen

challengesexpression systemshuman infectious diseasesvaccinevirusvirus-like particles

Substanzen

Vaccines, Virus-Like ParticleViral Vaccines

Autor:innen und Institutionen

  • Virology and Antiviral Strategies Research Unit UR17ES30, Higher Institute of Biotechnology, University of Monastir, Monastir, Tunisia.
  • USCR-SAG Unit, Higher Institute of Biotechnology, University of Monastirs, Monastir, Tunisia.
  • Department of Biological Sciences, College of Science, King Faisal University, Al-Ahsa, Saudi Arabia.

ORCID-Profile: Manel Ben M'hadheb, Mohammed A Almalki, Jawhar Gharbi

Förderung

  • Deanship of Scientific Research, King Faisal University
  • Tunisian National agency of research promotion
  • Ministry of Higher Education and Scientific Research

Zitieren

APA

Hadj Hassine, I., Ben M'hadheb, M., Almalki, M. A., & Gharbi, J. (2024). Virus‐like particles as powerful vaccination strategy against human viruses. Reviews in Medical Virology, 34(1). https://doi.org/10.1002/rmv.2498

Vancouver

Hadj Hassine I, Ben M'hadheb M, Almalki MA, Gharbi J. Virus‐like particles as powerful vaccination strategy against human viruses. Reviews in Medical Virology. 2024;34(1). doi:10.1002/rmv.2498

BibTeX
@article{HadjHassine2024,
  author = {Hadj Hassine, Ikbel and Ben M'hadheb, Manel and Almalki, Mohammed A and Gharbi, Jawhar},
  title = {Virus‐like particles as powerful vaccination strategy against human viruses},
  journal = {Reviews in Medical Virology},
  year = {2024},
  volume = {34},
  number = {1},
  doi = {10.1002/rmv.2498}
}
Kostenlos starten →